Filing Details

Accession Number:
0001209191-23-036087
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-09 20:00:30
Reporting Period:
2023-06-08
Accepted Time:
2023-06-09 20:00:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828673 Hcw Biologics Inc. HCWB Pharmaceutical Preparations (2834) 825024477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866254 Lee Flowers C/O Hcw Biologics Inc
2929 N. Commerce Parkway
Miramar FL 33025
Svp Of Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-08 5,356 $0.14 101,308 No 4 M Direct
Common Stock Acquisiton 2023-06-08 10,000 $2.16 111,308 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-06-08 5,356 $0.00 5,356 $0.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,501 2029-09-18 No 4 M Direct
Footnotes
  1. 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.